Therapies for Facial

Therapies for Facial Rejuvenation

At RCERT, we offer cutting-edge facial rejuvenation therapies that harness the power of cell technology, regenerative medicine, and non-invasive biotherapy to help you restore youthful skin, enhance collagen production, and slow visible signs of aging.

Our facial treatments are developed through clinical research and supported by advanced cell science — making them safe, effective, and suitable for all skin types.


✨ Our Key Facial Therapies

1️⃣ Exosome Facial Therapy

  • Uses cell-derived exosomes to promote skin regeneration, reduce inflammation, and stimulate collagen.

  • Benefits: Improved skin texture, reduced fine lines, enhanced hydration.

2️⃣ Mesenchymal Stem Cell (MSC) Facial Rejuvenation

  • MSCs support dermal repair, elastin production, and cell turnover.

  • Benefits: Youthful glow, tighter skin, improved elasticity.

3️⃣ Mitochondria-Enhanced Skin Therapy

  • Boosts cellular energy in skin cells, promoting faster repair and skin renewal.

  • Benefits: Revitalized, brighter, and firmer complexion.

4️⃣ Secretome Therapy

  • Delivers powerful regenerative factors to nourish skin and reduce signs of aging.

  • Benefits: Fades pigmentation, evens skin tone, and boosts radiance.

5️⃣ IV Anti-Aging Drip (Skin Focused)

  • Internal support through antioxidants, glutathione, and vitamins to promote skin clarity and tone.

  • Benefits: Brighter skin, detoxification, reduced oxidative stress.


🌿 Treatment Benefits

  • Non-surgical & minimally invasive

  • Promotes natural skin regeneration

  • Clinically backed by cellular science

  • Tailored programs for men & women

  • Safe for sensitive and aging skin


👩‍⚕️ Ideal For:

  • Fine lines and wrinkles

  • Dull or uneven skin tone

  • Acne scarring and enlarged pores

  • Sagging or aging skin

  • Post-inflammatory pigmentation


📍 Consult our medical team today to find the best facial therapy for your skin needs — powered by regenerative medicine and personalized treatment planning.